Physician profile
William Koeppel
NPI 1194162883
$1,470.22
in general payments reported to CMS, 2019-2025
19 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $422 · 2021: $229 · 2022: $35.30 · 2024: $87.55 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $262.17 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.98 | 2019-2022 | |
| Glaxosmithkline, LLC. | $159.33 | 2019-2024 | Bexsero, Shingrix, Arexvy |
| Novo Nordisk INC | $141.15 | 2021-2025 | Ozempic, Wegovy |
| Lilly USA, LLC | $128.33 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $119.82 | 2019-2024 | Farxiga |
| Abbvie INC. | $87.08 | 2024-2025 | |
| Gilead Sciences, INC. | $48.62 | 2019-2020 | |
| Abbott Laboratories | $41.33 | 2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $40.24 | 2020 | |
| Merck Sharp & Dohme LLC | $36.13 | 2019 | |
| Genentech USA, INC. | $35.86 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $29.39 | 2019-2020 | |
| Globus Medical, INC. | $27.14 | 2025 | Senza |
| Alkermes, INC. | $24.19 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $23.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.42 | 2024 | Spravato |
| Upsher-Smith Laboratories LLC | $18.82 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Koeppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.